Rubicon Research Private Limited: Drug Recall

Recall #D-0362-2022 · 12/31/2021

Class II: Risk

Recall Details

Recall Number
D-0362-2022
Classification
Class II
Product Type
Drug
Recalling Firm
Rubicon Research Private Limited
Status
Terminated
Date Initiated
12/31/2021
Location
Ambernath, N/A, India
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,684 1000-count bottles

Reason for Recall

Complaint received of foreign matter (metal) embedded in tablet.

Product Description

Metoprolol Tartrate Tablets, USP 25 mg, 1000 - count bottle, Rx Only, Distributed by: TruPharma, LLC. Tampa, FL 33609; Manufactured by: Rubicon Research Prvate Limited Ambernath, Dist. Thane, 421506 India. NDC 52817-360-00

Distribution Pattern

Product was distributed to one distributor who may have distributed the product further nationwide.

Other Recalls by Rubicon Research Private Limited

View all recalls by Rubicon Research Private Limited →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.